LEO Pharma A/S

Tweet this page
<
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
>
No longer registered as of 08 Mar 2023 - Registration as it was on 13 May 2022
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

50,000€ - 99,999€

Financial year: Jan 2020 - Dec 2020

Lobbyists (Full time equivalent)

1.25 Fte (3)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    LEO Pharma A/S   (LEO Pharma)

    EU Transparency Register

    10184967810-77 First registered on 23 Jan 2012

    Goals / Remit

    Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company.

    LEO Pharma develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients in more than 100 countries globally. To realise our vision of becoming the preferred dermatology care partner improving people’s lives around the world, we are expanding into new regions and markets, reaching more patients and societies with drugs and therapies that address unmet medical needs.

    LEO Pharma employs around 6,100 employees worldwide. The company is headquartered in Denmark and is fully owned by the LEO Foundation.

    Main EU files targeted

    REACH
    Incentives Review, including Orphan Medicinal Products Regulation (OMP)
    HTA proposal
    Falsified Medicines Directive
    Pharmaceutical strategy

    Address

    Head Office
    Industriparken, 55
    Ballerup 2750
    DENMARK
    EU Office
    Industriparken, 55
    Ballerup 2750
    DENMARK

    Website

    http://www.leo-pharma.com/

  • People

    Total lobbyists declared

    3

    Employment timeLobbyists
    50%2
    25%1

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 22 Dec 2024

    Name Start date End Date
    Ms Katja Murray 03 Mar 2015 27 Feb 2016
    Alberto GIUMMARRA 28 Jan 2015 26 Jan 2016
    Ms Anne Vibe Balthazar-Christensen 28 Jan 2015 26 Jan 2016

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Member of the ​The Danish Association of the Pharmaceutical Industry (Lif)
    Member of the International Federation of Pharmaceutical Manufactuers & Associations (IFPMA)
    Member of EFPIA
    Member of Confederation of Danish Industry (DI)

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2020 - Dec 2020

    Lobbying costs for closed financial year

    50,000€ - 99,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    accumen public affairs 50,000€ - 99,999€

    Intermediaries for current year

    None declared

    Closed year Costs

    50,000€ - 99,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    Meetings with MEPs
    Danish Pharma events in partnership with the Danish Permanent Representation to the EU
    Disease awareness activities
    World Psoriasis Day
    World Thrombosis Day
    World Eczema Day

    Other activities

    None declared

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 21 May 2021 Location Copenhagen
      Subject Industrial Strategy
      Cabinet Cabinet of Executive Vice-President Margrethe Vestager
      Portfolio Europe Fit for Digital Age
      Attending
      • Margrethe Vestager (Executive Vice-President)
      Other Lobbyists
Download this datacard